Drug major Sun Pharmaceutical Industries has acquired US-based Pharmalucence Inc for an undisclosed amount.
Pharmalucence, which has sterile injectable capacity in the US, has been acquired by one of the subsidiaries of Sun Pharma, the Mumbai-based firm said in a statement today.
The company, however, did not disclose the financial details of the deal.
More From This Section
Sun Pharma shares were trading at Rs 748.30, up 1.30 per cent from its previous close.